Core Laboratories Statistics
Core Laboratories (HJ1) Stock Statistics & Valuation Metrics
Total Valuation
Core Laboratories has a market cap or net worth of EUR 367.20M. The enterprise value is EUR 599.81M.
- Market Cap
- EUR 367.20M
- Enterprise Value
- EUR 599.81M
Share Statistics
Core Laboratories has 45,823,204 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 45,823,204
- Owned by Insiders
- 1.17%
- Owned by Institutions
- 58.45%
Financial Efficiency
Core Laboratories’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 6.83%.
- Return on Equity (ROE)
- 0.11
- Return on Assets (ROA)
- 0.05
- Return on Invested Capital (ROIC)
- 6.83%
- Return on Capital Employed (ROCE)
- 0.11
- Revenue Per Employee
- 159.55K
- Profits Per Employee
- 8,990.606
- Employee Count
- 3,300
- Asset Turnover
- 0.90
- Inventory Turnover
- 7.93
Valuation Ratios
The current PE Ratio of Core Laboratories is 26.32. Core Laboratories’s PEG ratio is -0.53.
- PE Ratio
- 26.32
- PS Ratio
- 0.79
- PB Ratio
- 1.50
- Price to FCF
- 19.63
- Price to Operating Cash Flow
- 16.93
- PEG Ratio
- -0.53
Income Statement
In the last 12 months, Core Laboratories had revenue of 526.52M and earned 29.67M in profits. Earnings per share was 0.68.
- Revenue
- 526.52M
- Gross Profit
- 94.28M
- Operating Income
- 50.49M
- Pretax Income
- 45.90M
- Net Income
- 29.67M
- EBITDA
- 71.12M
- Earnings Per Share (EPS)
- 0.68
Cash Flow
In the last 12 months, operating cash flow was 24.69M and capital expenditures -3.80M, giving a free cash flow of 20.89M billion.
- Operating Cash Flow
- 24.69M
- Free Cash Flow
- 20.89M
- Free Cash Flow per Share
- 0.45
Dividends & Yields
Core Laboratories pays an annual dividend of ―, resulting in a dividend yield of 0.47%
- Dividend Per Share
- ―
- Dividend Yield
- 0.47%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 5.22%
- Earnings Yield
- 3.81%
Stock Price Statistics
- Beta
- 0.77
- 52-Week Price Change
- -43.98%
- 50-Day Moving Average
- 9.18
- 200-Day Moving Average
- 11.39
- Relative Strength Index (RSI)
- 34.32
- Average Volume (3m)
- ―
Important Dates
Core Laboratories upcoming earnings date is Feb 03, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 28, 2026
- Next Earnings Date
- Feb 03, 2027
- Ex-Dividend Date
- ―
Financial Position
Core Laboratories as a current ratio of 2.02, with Debt / Equity ratio of 61.66%
- Current Ratio
- 2.02
- Quick Ratio
- 1.51
- Debt to Market Cap
- 0.15
- Net Debt to EBITDA
- 1.99
- Interest Coverage Ratio
- 4.78
Taxes
In the past 12 months, Core Laboratories has paid 15.51M in taxes.
- Income Tax
- 15.51M
- Effective Tax Rate
- 0.34
Enterprise Valuation
Core Laboratories EV to EBITDA ratio is 10.04, with an EV/FCF ratio of 25.89.
- EV to Sales
- 1.05
- EV to EBITDA
- 10.04
- EV to Free Cash Flow
- 25.89
- EV to Operating Cash Flow
- 21.91
Balance Sheet
Core Laboratories has EUR 21.38M in cash and marketable securities with EUR 161.97M in debt, giving a net cash position of -EUR 140.59M billion.
- Cash & Marketable Securities
- EUR 21.38M
- Total Debt
- EUR 161.97M
- Net Cash
- -EUR 140.59M
- Net Cash Per Share
- -EUR 3.07
- Tangible Book Value Per Share
- EUR 3.67
Margins
Gross margin is 17.67%, with operating margin of 7.57%, and net profit margin of 3.01%.
- Gross Margin
- 17.67%
- Operating Margin
- 7.57%
- Pretax Margin
- 5.38%
- Net Profit Margin
- 3.01%
- EBITDA Margin
- 10.43%
- EBIT Margin
- 7.52%
Analyst Forecast
The average price target for Core Laboratories is EUR 9.80, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
- Price Target
- EUR 9.80
- Price Target Upside
- 31.56% Upside
- Analyst Consensus
- Moderate Sell
- Analyst Count
- 1
- Revenue Growth Forecast
- -5.05%
- EPS Growth Forecast
- -45.58%
Scores
- Smart Score
- 4
- AI Score
- ―
